Health Canada has granted approval for Biogen’s Skyclarys (omaveloxolone) to treat Friedreich’s ataxia (FA), a rare, progressive neurodegenerative disease, in individuals aged 16 years and above. The ...
In addition, I think the recognition across all diseases where not everyone is going to be an expert in FA, and people can refer readily to tertiary care centers and even ordinary care centers that ...
In this video David Lynch, MD, PhD, discusses the effect Friedreich's ataxia can have on patients' quality of life.
Dunlavin was alive with the sounds of music and song when the community came together at St Nicholas Church of Ireland for a ...